These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 5416637)

  • 21. Effect of zinc and cadmium on guinea-pig complement.
    Amiraian K; McKinney JA; Duchna L
    Immunology; 1974 Jun; 26(6):1135-44. PubMed ID: 4851716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of the lytic effect of guinea pig complement by rabbit complement.
    Kempf RA; Gigli I; Austen KF
    J Immunol; 1969 Apr; 102(4):795-803. PubMed ID: 5768190
    [No Abstract]   [Full Text] [Related]  

  • 23. Immune hemolysis and the functional properties of the second (C2) and fourth (C4) components of complement. IV. Formation of EAC42 by treatment of C2 with trypsin in the presence of EAC4.
    Loos M; Borsos T; Rapp HJ
    J Immunol; 1972 Sep; 109(3):434-8. PubMed ID: 5055179
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison of complement activity in adult and preterm sheep serum.
    Ahmed S; Kemp MW; Payne MS; Kallapur SG; Stock SJ; Marsh HC; Jobe AH; Newnham JP; Spiller OB
    Am J Reprod Immunol; 2015 Mar; 73(3):232-41. PubMed ID: 25046333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Function and physical properties of two distinct forms of the first component of guinea pig complement.
    Thompson JJ; Hoffmann LG
    Immunochemistry; 1971 Feb; 8(2):169-84. PubMed ID: 5572748
    [No Abstract]   [Full Text] [Related]  

  • 26. PH OPTIMA IN IMMUNE HEMOLYSIS: A COMPARISON BETWEEN GUINEA PIG AND HUMAN COMPLEMENT.
    YACHNIN S; RUTHENBERG JM
    J Clin Invest; 1965 Jan; 44(1):149-58. PubMed ID: 14254250
    [No Abstract]   [Full Text] [Related]  

  • 27. Complement-fixing platelet iso-antibodies. IV. A comparison of human, guinea-pig and rabbit complement.
    Svejgaard A
    Vox Sang; 1969 Sep; 17(3):224-9. PubMed ID: 5352186
    [No Abstract]   [Full Text] [Related]  

  • 28. Restriction of complement-mediated membrane damage by the eighth component of complement: a dual role for C8 in the complement attack sequence.
    Nemerow GR; Yamamoto KI; Lint TF
    J Immunol; 1979 Sep; 123(3):1245-52. PubMed ID: 469249
    [No Abstract]   [Full Text] [Related]  

  • 29. A new immunochemical assay for the detection of the first component of complement C1.
    Colten HR; Spalter JS
    J Immunol; 1970 May; 104(5):1043-7. PubMed ID: 5444335
    [No Abstract]   [Full Text] [Related]  

  • 30. Preparation and partial characterization of sheep erythrocyte-antibody-complement intermediate.
    Rommel FA; Stolfi R
    Immunology; 1968 Oct; 15(4):469-79. PubMed ID: 5696260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The ninth component of human complement: isolation, description and mode of action.
    Hadding U; Müller-Eberhard HJ
    Immunology; 1969 Jun; 16(6):719-35. PubMed ID: 4182367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. C3 inactivator of man. I. Hemolytic measurement by the inactivation of cell-bound C3.
    Ruddy S; Austen KF
    J Immunol; 1969 Mar; 102(3):533-43. PubMed ID: 5813010
    [No Abstract]   [Full Text] [Related]  

  • 33. Complement lysis of human erythrocytes. III. Differing effectiveness of human and guinea pig C9 on normal and paroxysmal nocturnal hemoglobinuria cells.
    Rosenfeld SI; Packman CH; Jenkins DE; Countryman JK; Leddy JP
    J Immunol; 1980 Nov; 125(5):2063-8. PubMed ID: 6776186
    [No Abstract]   [Full Text] [Related]  

  • 34. Highlights of complement research during the past twenty-five years.
    Mayer MM
    Immunochemistry; 1970 May; 7(5):485-96. PubMed ID: 4920409
    [No Abstract]   [Full Text] [Related]  

  • 35. Studies on immune hemolysis: preparation of a stable and highly reactive complex of sensitized erythrocytes and the first component of complement (EAC'1): inactivation of cell-fixed C'1 by some complement reagents.
    KLEIN PG
    J Exp Med; 1960 Jan; 111(1):77-91. PubMed ID: 13848490
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The biologic activities of guinea pig antibodies. II. Modes of complement interaction with gamma 1 and gamma 2-immunoglobulins.
    Sandberg AL; Osler AG; Shin HS; Oliveira B
    J Immunol; 1970 Feb; 104(2):329-34. PubMed ID: 4189670
    [No Abstract]   [Full Text] [Related]  

  • 37. Immune haemolysis: reaction of the terminal complement component.
    Götze O; Haupt I; Fischer H
    Nature; 1968 Mar; 217(5134):1165-7. PubMed ID: 4966850
    [No Abstract]   [Full Text] [Related]  

  • 38. Purification of a human serum protein ("factor E") which enhances cobra venom factor-induced indirect lysis. Identification with the fifth component of complement.
    Lynen R; Vogt W; Schmidt G; Dieminger L
    Z Immunitatsforsch Exp Klin Immunol; 1976 Apr; 151(2):105-16. PubMed ID: 134530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of the first component of complement evidence for an internal activation step.
    Loos M; Borsos T; Rapp HJ
    J Immunol; 1972 Mar; 108(3):683-8. PubMed ID: 5011751
    [No Abstract]   [Full Text] [Related]  

  • 40. Activation of the fifth and sixth component of the complement system: similarities between C5b6 and C(56)a with respect to lytic enhancement by cell-bound C3b or A2C, and species preferences of target cell.
    Hänsch GM; Hammer CH; Mayer MM; Shin ML
    J Immunol; 1981 Sep; 127(3):999-1002. PubMed ID: 6911149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.